Dudediligence.

Bristol-Myers Squibb Company

BMYNYSE · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$11.89BSep ’24$12.34BDec ’24$11.20BMar ’25$12.27BJun ’25$12.22BSep ’25$12.50BDec ’25$11.49BMar ’26$12.97BJun ’26
Net income, by quarter
$1.21BSep ’24$72.0MDec ’24$2.46BMar ’25$1.31BJun ’25$2.20BSep ’25$1.09BDec ’25$2.68BMar ’26$3.32BJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$46.38B$46.16B$45.01B$48.30B$48.19B
Gross profit$36.45B$36.02B$34.31B$34.33B$34.26B
Net income$6.99B$6.33B$8.03B−$8.95B$7.05B
Operating cash flow$16.21B$13.07B$13.86B$15.19B$14.16B
Free cash flow$15.23B$11.95B$12.65B$13.94B$12.85B
Cash$13.98B$9.12B$11.46B$10.35B$10.21B
Debt$44.55B$39.32B$39.77B$49.65B$45.11B
Shares outstanding2.90B2.90B2.90B2.90B2.90B